COVID qPCR Reagents

Highlights

True Blue Bio COVID-19 qPCR Reagents are designed to support rapid, accurate, and reliable detection of SARS-CoV-2 in clinical samples. Built on optimized real-time PCR chemistry, the assay delivers high sensitivity and specificity to confidently identify viral RNA across a wide range of viral loads, while fitting seamlessly into routine laboratory workflows.

By targeting conserved regions of the SARS-CoV-2 genome, the assay enables dependable detection in a single run, supporting timely diagnosis and effective patient management. The clear and precise results assist clinicians and public health teams in making informed decisions for infection control, treatment, and surveillance.

The ready-to-use reagent format minimizes hands-on time and reduces the risk of technical variation, ensuring consistent and reproducible results across users and testing runs. Full compatibility with standard real-time PCR instruments allows straightforward integration into existing laboratory infrastructure without additional equipment.

Each reagent set is manufactured under strict quality control standards, including comprehensive assay validation and rigorous lot-to-lot testing. This ensures robust performance, high accuracy, and minimal cross-reactivity, even when working with complex respiratory specimens.

When paired with PCRopsis technology, True Blue Bio COVID-19 qPCR Reagents support flexible workflows, including extraction-free and direct-to-amplification options. These capabilities reduce turnaround times, optimize laboratory efficiency, and lower operational costs while maintaining strong analytical performance and clinical confidence.

Pathogen Coverage - 1